๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Alzheimer Disease
Clinical trial register · China

Alzheimer Disease Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 30 Shanghai 12 Hangzhou 10 Guangzhou 9 Chongqing 7
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xuanwu Hospital, Beijing14 Ruijin Hospital5 First Affiliated Hospital of Zhejiang University3 Second Affiliated Hospital, Zhejiang University, School of Medicine2 Capital Medical University2
Site location
Beijing30 Shanghai12 Hangzhou10 Guangzhou9 Chongqing7
All 50 locations
Target enrolment
to

Alzheimer Disease trials in China

61 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Transcranial Random Noise (tRNS) for BPSD in Alzheimer's Disease: A Double-blind Randomized Controlled Trial
NCT07827196Transcranial Random Noise Stimulation (tRNS), Electroencephalography, Alzheimer Disease, BPSD (Behavioral and Psychological Symptoms of Dementia)
Anhui Medical University
Not applicable
40
Hefei
2026-09-01
Recruiting
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
NCT07688460Alzheimer Disease
DrugLecanemab
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 4
100
Yiwu
2026-07-10
Not yet open
Silkworm Pupa Powder Improves Alzheimer's Disease
NCT07638449Alzheimer Disease, Sarcopenia, Asthenia, Frailty
Zhejiang Provincial Tongde Hospital
Not applicable
100
Hangzhou
2026-06-01
By invitation
Wearables-and Blood-based Biomarkers-incorporated Modernisation of Circadian Rhythm Disruption Management in People Living With Alzheimer's Dementia: A Stepwise Study From Digital Inclusivity, Digital Therapy, to Digital Phenotyping and Biomarker Exploration
NCT07222449Alzheimer Disease
China Medical University Hospital
Not applicable
162
2026-05-11
Recruiting
Donanemab (LY3002813) Trial in Chinese Participants With Cognitively Unimpaired (Preclinical) Alzheimer's Disease
NCT07571161Alzheimer Disease
DrugDonanemab
Eli Lilly and Company
Phase 3
140
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hefei
2026-04-30
Recruiting
The Effect of Sequential Therapy on Alzheimer's Disease
NCT07768579Mild Cognitive Impairment Due to Alzheimer Disease, Alzheimer Disease
Dongzhimen Hospital, Beijing
Observational
600
Beijing
2026-04-30
Recruiting
Deep Cervical LymphatIc-Venous Anastomosis for Alzheimer's Disease
NCT07294885Alzheimer Disease
General Hospital of Shenyang Military Region
Not applicable
50
Shenyang
2026-03-20
Not yet open
Digital Technology Combined With Blood Marker Screening and Diagnosis for Community Populations Based on Classification Theory: an Integrated Study
NCT07286812Alzheimer Disease
First Hospital of China Medical University
Observational
1,000
Shenyang
2025-12-25
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229Alzheimer Disease, Agitation
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
650
Beijing, Haidian District, Guangzhou, Shenzhen, Changsha, Nanjing, Tianjin, Hangzhou
2025-12-02
Not yet open
Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)
NCT07230158Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
160
Beijing
2025-11-30
By invitation
Efficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's Disease
NCT07543094Alzheimer Disease
Ruijin Hospital
Not applicable
40
Shanghai
2025-11-01
Not yet open
An Exploratory Study of Near-infrared Light Therapy for Mild to Moderate Alzheimer's Disease
NCT06836180Alzheimer Disease
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
40
Beijing
2025-10-30
Recruiting
Ozanimod in Patients With Alzheimer's Disease
NCT06862960Alzheimer Disease
DrugOzanimod
ChenXiaoChun
Phase 2
40
Fuzhou
2025-08-13
Recruiting
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
NCT07323927Alzheimer Disease
DrugGalcanezumab
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
10
Beijing
2025-08-01
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
NCT07011732Alzheimer Disease
DrugsKarX-EC·KarXT
Bristol-Myers Squibb
Phase 3
426
Beijing, Haidian District, Chongqing, Guangzhou, Shenzhen, Changsha, Nanjing, Shanghai
2025-07-10
Recruiting
Effects and Mechanisms of Temporal Interference Brain Stimulation on Memory Function in Preclinical Alzheimer's Disease
NCT07031687Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
1,200
Sanya, Beijing
2025-07-01
Not yet open
hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative Diseases
NCT06607900Alzheimer Disease, Parkinson Disease, Lewy Body Dementia, Multiple System Atrophy
Xuanwu Hospital, Beijing
Phase 1
120
Beijing
2025-07-01
Recruiting
Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)
NCT07089303Alzheimer Disease, Mild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital
Observational
750
Beijing
2025-07-01
Recruiting
miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction
NCT07353502Alzheimer Disease, Biomarker in Early Diagnosis
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
40
Yiwu
2025-06-20
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
NCT06808984Agitation, Alzheimer Disease
DrugIrafamdastat
Celgene
Phase 2
120
Hefei, Beijing, Wuhan, Nanjing, Shanghai Shi, Hangzhou
2025-06-09
Not yet open
Deep Cervical Lymphaticovenous Anastomosis Surgery for Moderate-to-Advanced Dementia Patients
NCT06978946Alzheimer Disease, Lewy Body Dementia (LBD), Frontotemporal Dementia (FTD), Dementia
RenJi Hospital
Not applicable
85
Shanghai
2025-05-28
Recruiting
Near-Infrared Light Therapy Combined With Lecanemab for Mild Alzheimer's Disease
NCT06992804Alzheimer Disease
Xuanwu Hospital, Beijing
Phase EARLY_PHASE1
20
Beijing
2025-05-28
Recruiting
Lecanemab for Early Onset Familial Alzheimer's Disease
NCT06883019Alzheimer Disease
RenJi Hospital
Observational
114
Beijing, Guangdong, Guizhou, Jiangsu, Shanghai, Sichuan, Tianjin, Zhejiang
2025-03-13
Recruiting
Clinical Analgesic Management in Dementia
NCT07323914Alzheimer Disease
Xuanwu Hospital, Beijing
Phase 3
10
Beijing
2025-03-01
Recruiting
An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
NCT06852352Alzheimer Disease, Parkinson Disease
Zhejiang Provincial People's Hospital
Not applicable
160
Hangzhou
2025-02-28
Recruiting
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases ๏ผˆACT-AD๏ผ‰
NCT06669182Alzheimer Disease, Transcranial Magnetic Stimulation, Cerebellum
Xijing Hospital
Not applicable
100
Xi'an
2025-01-07
Recruiting
Study Safety and Efficacy of Deep Brain Stimulation (DBS) and Cervical Deep Lymphoid-venous Anastomosis (LVA) in Alzheimer's Disease
NCT07094438Alzheimer Disease
Chinese PLA General Hospital
Phase 1
98
Beijing
2025-01-01
Not yet open
Combined Aerobic Exercise and Cognitive Training in Seniors With Genetic Susceptibility for Alzheimer's Disease
NCT05163067Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
200
Beijing
2024-12
Not yet open
Combined Aerobic Exercise and Cognitive Training in Seniors at Increased Risk for Alzheimer's Disease
NCT05163626Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
200
Beijing
2024-12
Recruiting
Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD
NCT07115238Alzheimer Disease, Neurofibrillary Tangle
Sinotau Pharmaceutical Group
Phase 3
354
Beijing
2024-11-20
Recruiting
A Study of CM383 in Patients With Alzheimer's Disease Related Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT06619613Alzheimer Disease
Keymed Biosciences Co.Ltd
Phase 1
48
Hefei
2024-11-08
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787Alzheimer Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
406
Beijing, Chongqing, Guangzhou, Shenzhen, Nanjing, Zhenjiang, Xi'an, Shanghai
2024-09-26
Recruiting
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
NCT07153848Alzheimer Disease
First Affiliated Hospital of Zhejiang University
Observational
400
Hangzhou
2024-07-01
Recruiting
Prospective Cohort Study of Patients With Early Alzheimer's Disease Treated With Lecanemab
NCT06741553Alzheimer Disease, Mild Cognitive Impairment (MCI)
DrugLecanemab
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
120
Hangzhou
2024-06-28
Recruiting
The Peripheral Blood Multi-Omics Study on Sleep Loss
NCT06492109Sleep Deprivation, Aging, Alzheimer Disease, Healthy Lifestyle
First Affiliated Hospital of Zhejiang University
Not applicable
60
Hangzhou
2024-06-20
Recruiting
Clinical Evaluation of Acupuncture Treatment on Alzheimer's Disease in APOE e4 Carriers and Non-Carriers
NCT06417086Alzheimer Disease, Cognitive Impairment
DrugDonepezil
ZhanYJ
Not applicable
176
Shanghai
2024-06-01
Not yet open
Cognitive Impairment Cohort Study of the Elderly Population in YuGarden
NCT06325527Alzheimer Disease, Neurodegenerative Diseases, Cognitive Impairment, Mild Cognitive Impairment
Ruijin Hospital
Observational
1,872
Shanghai
2024-04-01
Recruiting
Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease
NCT06385106Alzheimer Disease
First Affiliated Hospital of Zhejiang University
Not applicable
30
Hangzhou
2024-03-16
Recruiting
A Longitudinal Study to Explore the Impact of Gut Microbiome on Brain Health in Alzheimer's Disease
NCT06837272Alzheimer Disease, Gut Microbiota, Metabonomics, Magnetic Resonance Imaging
Jining Medical University
Observational
285
Jining
2024-01-01
Active, closed
Transcranial Near-infrared Light Therapy for Mild-Moderate Alzheimer's Disease (NIR4AD)
NCT06160908Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
38
Beijing
2023-12-12
Recruiting
Study on the Health Economic Burden of Alzheimer's Disease in China
NCT05995418Alzheimer Disease
Xuanwu Hospital, Beijing
Observational
9,510
Beijing
2023-07-01
Recruiting
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
NCT05886114Cognitive Impairment, Alzheimer Disease, Vascular Cognitive Impairment, Dement
Zhejiang University
Not applicable
1,200
Hangzhou
2023-05-28
Not yet open
Cognitive Impairment Cohort Study of the Elderly Population in SheMountain
NCT05667935Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
2,000
Shanghai
2022-12-26
Active, closed
Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)
NCT05531526Alzheimer Disease
AriBio Co., Ltd.
Phase 3
1,535
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hefei, Heping, Nanchang
2022-12-23
Not yet open
Implantable Vagus Nerve Stimulation Modulation of Coeruleus-Norepinephrine Network for Mild-Moderate AD Patients
NCT05575271Alzheimer Disease
Xuanwu Hospital, Beijing
Not applicable
6
Beijing
2022-11-01
Active, closed
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
NCT05508789Alzheimer Disease, Dementia, Brain Diseases, Central Nervous System Diseases
DrugDonanemab
Eli Lilly and Company
Phase 3
1,500
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou Fujian, Guangzhou, Haidian District
2022-10-10
Recruiting
Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
NCT06092125Alzheimer Disease, Parkinson Disease, Epilepsy, Malignant Brain Tumor
Xuanwu Hospital, Beijing
Observational
2,300
Beijing
2022-10-01
Recruiting
Establishment of the Chinese Preclinical Alzheimer's Disease Study With Multiple Neuroimaging
NCT06827678Alzheimer Disease, Positron Emission Tomography
Huashan Hospital
Observational
3,000
Shanghai
2022-08-01
Recruiting
Application of AI Technology for the Diagnosis and Treatment of Geriatric Diseases
NCT06295263Parkinson Disease, Alzheimer Disease, Nervous System Diseases, Geriatric Diseases
Qilu Hospital of Shandong University
Observational
460
Jinan
2022-03-01
Recruiting
Shanghai At Risk for Alzheimer's Disease: a Cohort Study
NCT05597410Alzheimer Disease, Dementia, Neurodegenerative Diseases, Cognitive Impairment
Ruijin Hospital
Observational
3,418
Shanghai
2022-03-01
Active, closed
Long-term Efficacy and Safety Study of GV-971
NCT05181475Alzheimer Disease
DrugSodium Oligomannate
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
800
Beijing, Chongqing, Lanzhou, Foshan, Guangzhou, Shenzhen, Guiyang, Baoding
2021-12-07
Recruiting
First-in-Human Evaluation of an Astrocytic Glutamate Transporter (EAAT2) PET Tracer in Dementia
NCT05374278Alzheimer Disease, Frontotemporal Dementia, Dementia
David Wilson
Phase 1/2
102
2021-11-02
Active, closed
A Clinical Study to Evaluate the Long-Term Safety Sodium Oligomannate Capsules (GV-971)
NCT05058040Alzheimer Disease
DrugSodium Oligomannate
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Phase 4
2,500
Hefei, Beijing, Chongqing, Xianmencun, Dongguan, Guangzhou, Shenzhen, Zhuhai
2021-06-02
Recruiting
Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease
NCT06442852Alzheimer Disease, MicroRNAs
Jiajie Chen
Observational
500
Wuhan
2021-04-03
Recruiting
China Longitudinal Aging and Cognitive Impairment Study
NCT05468905Aging, Mild Cognitive Impairment, Alzheimer Disease, Neurodegeneration
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
4,000
Hangzhou, Lishui
2021-01-10
Recruiting
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia
NCT06534658Alzheimer Disease, Image
Ruijin Hospital
Observational
1,000
Beijing, Hanzhong, Cangzhou, Shijiazhuang, Qingdao, Shanghai, Shenyang
2020-07-30
Recruiting
Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
NCT04575337Alzheimer Disease
Capital Medical University
Observational
6,000
Beijing
2020-05-28
Recruiting
Cognitive Impairment in Ageing People
NCT04360200MCI, Alzheimer Disease, VAD - Vascular Dementia, Cognitive Impairment
Yamei Tang
Observational
5,000
Guangzhou
2020-04-01
Recruiting
Clinical Evaluation on the Therapeutic Effect of Acupuncture Treatment for Alzheimer's Disease
NCT03810794Alzheimer Disease, Cognitive Impairment
DrugDonepezil
Jian Pei,MD
Not applicable
180
Shanghai
2019-03-01
Recruiting
Biomarker-based Alzheimer's Disease Cohort Study (BASIC)
NCT07109999Alzheimer Disease
Xuanwu Hospital, Beijing
Observational
2,835
Beijing
2019-01-01
Recruiting
The Chinese Familial Alzheimer's Network
NCT03657732Alzheimer Disease, Familial Alzheimer Disease (FAD)
Capital Medical University
Observational
40,000
Hefei, Changping, Chaoyang, Fengtai, Haidian, Xicheng, Yuzhong, Fujian
2005-01-10
Rows per page Showing 1–61 of 61
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/alzheimer-disease

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 61 of those studies listing the condition Alzheimer Disease.

How many Alzheimer Disease trials are recruiting in China?

43 of the 61 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 11 have not yet opened recruitment, 5 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Alzheimer Disease), 61 studies
PhaseStudiesRecruitingShare
Observational211834.4%
Not applicable201132.8%
Phase 38613.1%
Phase 1324.9%
Phase 4314.9%
Phase EARLY_PHASE1324.9%
Phase 2223.3%
Phase 1/2111.6%

Most active sponsors

Lead sponsors with the most studies (Alzheimer Disease)
Lead sponsorStudiesRecruiting
Xuanwu Hospital, Beijing147
Ruijin Hospital52
First Affiliated Hospital of Zhejiang University33
Bristol-Myers Squibb22
Capital Medical University22
Chinese PLA General Hospital22
Eli Lilly and Company21
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.20
RenJi Hospital21
Second Affiliated Hospital, Zhejiang University, School of Medicine22
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.